Bakar Bio Labs Fireside Chat: David Schaffer & Corey Goodman

​The US biotech landscape has shifted fast. All the way from pre-seed to the public market, financing continues to be challenging. On a related note, recent data suggests close to half of new biotech business development deals now involve Chinese assets, and US companies are rethinking where they run trials, whom they manufacture with, and how they protect what they're building.

​During this fireside chat on June 4th, David Schaffer (Director, Bakar Labs) will sit down with Corey Goodman from venBio to talk about what this new reality looks like from the founder and investor perspectives. Corey and David will dig into how venBio’s portfolio companies are managing these changes, where investors are heading when they look outside the US, and what it takes for US biotech to stay competitive in rapidly changing environment. We hope to see you there!

​While we prefer you to be in person, we understand that teams are spread across many locations. We're adding a zoom option for this lunch and learn. Join virtually here!